New hope for tough brain tumors: targeted radiation trial launches
NCT ID NCT06326190
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called 177Lu-DOTATATE for people with recurrent meningioma, a type of brain tumor that has come back after surgery or radiation. The drug delivers radiation directly to tumor cells by targeting a protein found on these tumors. About 136 adults will be randomly assigned to receive the drug or standard care, and researchers will track how long the tumor stays under control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT MENINGIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O Landeskrankenhaus - Innsbruck Universitaetsklinik
RECRUITINGInnsbruck, 6020, Austria
-
Assistance Publique - Hopitaux de Marseille APHM - Hopital de La Timone (APHM)
RECRUITINGMarseille, 13005, France
-
CHRU de Nancy - Hopitaux De Brabois
RECRUITINGVandœuvre-lès-Nancy, 54511, France
-
CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer
RECRUITINGLyon, 69500, France
-
CHU de Toulouse - Institut Claudius Regaud - IUCT oncopole
RECRUITINGToulouse, 31100, France
-
Centre Eugene Marquis
RECRUITINGRennes, 35042, France
-
Centre Leon Berard
RECRUITINGLyon, 69008, France
-
Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
Hospital Universitario 12 De Octubre
RECRUITINGMadrid, 28041, Spain
-
Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern
RECRUITINGMünchen, 81377, Germany
-
Oncology Institute of Southern Switzerland (IOSI) - Ospedale San Giovanni
NOT_YET_RECRUITINGBellinzona, 6500, Switzerland
-
Oslo University Hospital - Radiumhospitalet
RECRUITINGOslo, 0379, Norway
-
St Olavs University Hospital - St. Olavs Hospital, Trondheim University Hospital
RECRUITINGTrondheim, 7030, Norway
-
UniversitaetsSpital Zurich - Neurology Clinic
NOT_YET_RECRUITINGZurich, 8091, Switzerland
-
Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH unikliniken
RECRUITINGVienna, 1090, Austria
-
Universitaetsklinikum - Essen
RECRUITINGEssen, 45147, Germany
-
Universitaetsklinikum Heidelberg - UniversitaetsKlinikum Heidelberg - Head Hospital
RECRUITINGHeidelberg, 69120, Germany
-
University Frankfurt - Goethe Univ. - University Hospital Frankfurt- Klinik für Neurologie Funktionsbereich Neuroonkologie
RECRUITINGFrankfurt, 60590, Germany
-
Vall D Hebron - Hospital Universitari Vall d'Hebron -Vall d'Hebron Institut Oncologia
RECRUITINGBarcelona, 08035, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New radiation approach aims to stop brain tumor regrowth
- New combo therapy aims to stop returning brain tumors
- New radiation strategy aims to tackle tough brain tumors
- New hope for inoperable brain tumors: radioactive drug trial launches
- Immunotherapy meets radiation in fight against recurrent meningioma
- New drug combo targets tough brain tumors